250 related articles for article (PubMed ID: 9234808)
1. Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.
Charoenvit Y; Fallarme V; Rogers WO; Sacci JB; Kaur M; Aguiar JC; Yuan LF; Corradin G; Andersen E; Wizel B; Houghten RA; Oloo A; De la Vega P; Hoffman SL
Infect Immun; 1997 Aug; 65(8):3430-7. PubMed ID: 9234808
[TBL] [Abstract][Full Text] [Related]
2. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
[TBL] [Abstract][Full Text] [Related]
3. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers.
Wizel B; Houghten R; Church P; Tine JA; Lanar DE; Gordon DM; Ballou WR; Sette A; Hoffman SL
J Immunol; 1995 Jul; 155(2):766-75. PubMed ID: 7541824
[TBL] [Abstract][Full Text] [Related]
4. Induction of murine cytotoxic T lymphocytes against Plasmodium falciparum sporozoite surface protein 2.
Wizel B; Rogers WO; Houghten RA; Lanar DE; Tine JA; Hoffman SL
Eur J Immunol; 1994 Jul; 24(7):1487-95. PubMed ID: 7517870
[TBL] [Abstract][Full Text] [Related]
5. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Plasmodium falciparum sporozoite surface protein 2.
Rogers WO; Malik A; Mellouk S; Nakamura K; Rogers MD; Szarfman A; Gordon DM; Nussler AK; Aikawa M; Hoffman SL
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9176-80. PubMed ID: 1409621
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
[TBL] [Abstract][Full Text] [Related]
9. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E
Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363
[TBL] [Abstract][Full Text] [Related]
10. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
11. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
Charoenvit Y; Majam VF; Corradin G; Sacci JB; Wang R; Doolan DL; Jones TR; Abot E; Patarroyo ME; Guzman F; Hoffman SL
Infect Immun; 1999 Nov; 67(11):5604-14. PubMed ID: 10531206
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
Wang LT; Pereira LS; Kiyuka PK; Schön A; Kisalu NK; Vistein R; Dillon M; Bonilla BG; Molina-Cruz A; Barillas-Mury C; Tan J; Idris AH; Francica JR; Seder RA
PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
[TBL] [Abstract][Full Text] [Related]
13. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
Chatterjee S; Wery M; Sharma P; Chauhan VS
Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
15. Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum.
Del Giudice G; Tougne C; Renia L; Ponnudurai T; Corradin G; Pessi A; Verdini AS; Louis JA; Mazier D; Lambert PH
Mol Immunol; 1991 Sep; 28(9):1003-9. PubMed ID: 1922106
[TBL] [Abstract][Full Text] [Related]
16. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
[TBL] [Abstract][Full Text] [Related]
17. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
[TBL] [Abstract][Full Text] [Related]
18. Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.
Carapau D; Mitchell R; Nacer A; Shaw A; Othoro C; Frevert U; Nardin E
Infect Immun; 2013 Dec; 81(12):4350-62. PubMed ID: 24042110
[TBL] [Abstract][Full Text] [Related]
19. Novel sporozoite-based ELISpot assay to assess frequency of parasite-specific B cells after vaccination with irradiated sporozoites.
Atre T; Robinson TM; Savransky T; Dutta S; Epstein JE; Bergmann-Leitner ES
Malar J; 2019 May; 18(1):186. PubMed ID: 31142328
[TBL] [Abstract][Full Text] [Related]
20. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.
Przysiecki C; Lucas B; Mitchell R; Carapau D; Wen Z; Xu H; Wang XM; Nahas D; Wu C; Hepler R; Ottinger E; Ter Meulen J; Kaslow D; Shiver J; Nardin E
Front Cell Infect Microbiol; 2012; 2():146. PubMed ID: 23226683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
